USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
VIVO BIOSCIENCES, INC.
Address:
1601 12TH AVE S
BIRMINGHAM, AL
Phone:
N/A
URL:
N/A
EIN:
30543515
DUNS:
168161532
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $431,894.00 3
SBIR Phase II $1,439,432.00 2

Award List:

Phage Microarray Discovery of New Tumor Autoantibodies

Award Year / Program / Phase:
2004 / SBIR / Phase I
Award Amount:
$130,240.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): The diagnosis and treatment of prostate cancer will benefit greatly from the availability of simple, inexpensive blood tests which enable clinicians to distinguish more accurately between aggressive and non aggressive tumors. The long-term goal of this SBIR… More

New In Vitro 3D Functional Model of Tumorigenesis

Award Year / Program / Phase:
2006 / SBIR / Phase II
Award Amount:
$700,366.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): In our initial R&D effort we successfully demonstrated the feasibility of a novel human biomatrix system (HuBiogel) in designing 3D bioassay system for in vitro examination of tumorigenesis process. The overall goal was and is to develop and commercialize these… More

Diagnostic IgM and IgA Autoantibodies for Prostate Cancer

Award Year / Program / Phase:
2009 / SBIR / Phase I
Award Amount:
$171,654.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Over 30,000 Americans die each year from prostate cancer, making it the second most lethal form of cancer affecting men in the U.S. Many of these deaths could be prevented if the cancers were detected before the tumor e scaped the prostate. Our goal for this… More

New In Vitro Human Liver Toxicity Bioassay System

Award Year / Program / Phase:
2010 / SBIR / Phase I
Award Amount:
$130,000.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Abstract: The overall goal of this SBIR proposal is to develop and commercialize a new human liver bioassay system for real time, long-term toxicity analysis of chemical agents or drugs in vitro. At present, liver studi es are mostly performed using hepatocytes… More

New In Vitro Human Liver Toxicity Bioassay System

Award Year / Program / Phase:
2012 / SBIR / Phase II
Award Amount:
$739,066.00
Agency:
HHS
Principal Investigator:
Raj K. Singh – 205-930-0001
Abstract:
DESCRIPTION (provided by applicant): The overall objective of this SBIR proposal is to develop and commercialize a human 3D or mini- liver bioassay system suitable for real-time analysis of metabolic functions and long-term drug toxicity profiles. At present, liver functions are mostly studied using… More